Xyloneural, Injektionslösung

7680427730266 CH-42773 Injektionslösung
Xyloneural, Injektionslösung
Xyloneural, Injektionslösung
Xyloneural, Injektionslösung
1 / 3
google

Article details

Package size
50 x 5 mL
Selling units
250
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/11/2021
Summary of Product Characteristics
Français
17/11/2021
Summary of Product Characteristics
Italien
17/11/2021

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.56 MG Substance HBESI

Authorization holder

Gebro Pharma AG

4410 Liestal

Authorization information

Swissmedic authorization number
42773
Drug name
Xyloneural, Injektionslösung
Galenic form
LSINJ
ATC Code
N01BB02
Authorization status
Revoked/Withdrawn
Dispensing category
B
First authorization
15/01/1981
Authorization expiration date
31/07/2025
IT Number
01.02.2.
Domain
Human medicine
Field of application
Neuraltherapie

Package details

Description (FR)
XYLONEURAL sol inj s cons 50 amp 5 ml
Description (DE)
XYLONEURAL Inj Lös o Kons 50 Amp 5 ml
Market launch
15/01/1981
Market withdrawal
31/07/2025
Narcotic (BTM)
No

Other package sizes (2)

XYLONEURAL sol inj s cons 5 amp 5 ml
5 x 5 mL AMP
GTIN: 7680427730181
View
XYLONEURAL sol inj flac 50 ml
1 x 50 mL DUR
GTIN: 7680427730341
Not in V1